Coronavirus (COVID-19) Manufacture And Supply Of Hand .

3y ago
52 Views
2 Downloads
354.45 KB
12 Pages
Last View : 4d ago
Last Download : 3m ago
Upload by : Casen Newsome
Transcription

Coronavirus (COVID-19) manufacture andsupply of hand sanitisersManufacturers and suppliers of hand sanitisers must comply with the relevant laws. This may mean your productneeds to be authorised by HSE.Check which regulations apply to your productAll hand cleaning and sanitising products (such as liquids, gels and soaps) are regulated in the UK.If you are manufacturing or importing hand sanitising products you must comply with whichever regulations arerelevant for each product in your range.Hand sanitising products fall into one of three regulatory groups depending on the products’ intended use, function,composition or how they are described: Products primarily used to clean and/or moisturise skin while providing a secondary antimicrobial effect,such as a liquid soap or solid soap bars, are classed as a cosmetic. The regulations that apply are theCosmetic Product Regulations t-safety/cosmeticproducts). Contact your local Trading Standards office (www.gov.uk/find-local-trading-standards-office) forinformation and advice. Products which make claims to treat/prevent infections associated with specifically named pathogens (suchas COVID-19) are classed as medicines, as are products specifically used as surgical scrubs for use inoperating theatres.Marketing Authorisations marketing-authorisationsvariations-licensing) are required for medicines. Contact the Medicines and Healthcare products RegulatoryAgency (MHRA) at borderline medicine@mhra.gov.uk for information and advice. Products primarily claiming to kill germs, disinfect or sanitise using an active antimicrobial ingredient, suchas hand sanitisers, are classed as a biocide. Please note that general hand sanitiser products are notpermitted to name specific pathogens (such as COVID-19).

This guidance gives information on the regulatory requirements for hand sanitisers under biocides. Contact HSE’sbiocides helpdesk at biocidesenquiries@hse.gov.uk for further advice.General legal requirements for biocidal hand sanitiserproductsClassification, Labelling and Packaging of substances and mixtures (CLP)If you are supplying biocidal hand sanitiser products, you must comply with relevant legislation on Classification,Labelling and Packaging of substances and Mixtures (CLP) .Labels must not be misleading in respect of the risks from the product to human health, animal health or theenvironment, or in relation to its efficacy.Labels must not mention the terms ‘low-risk biocidal product’, ‘non-toxic’, ‘harmless’, ‘natural’, ‘environmentallyfriendly’, ‘animal friendly’ or similar indications, or include any medicinal claims.AdvertisingAdverts for biocidal hand sanitiser products must not be misleading in respect of the risks from the product tohuman health, animal health or the environment, or in relation to its efficacy.Adverts must not mention the terms ‘low-risk biocidal product’, ‘non-toxic’, ‘harmless’, ‘natural’, ‘environmentallyfriendly’, ‘animal friendly’ or similar indications, or include any medicinal claims.Record keepingYou must keep records reporting.htm) of the quantity andsafety of the biocidal hand sanitiser products you supply in the UK.REACHIf you import biocidal hand sanitiser products from outside the EU, the REACH Regulation (1907/2006) may apply tothe individual non-active substances/ingredients present in the product.

REACH has a registration duty which applies to those that manufacture or import chemical substances into the EU ina quantity of 1 tonne per year or more. In the case of a mixture, it is the individual substances/ingredients within themixture that are subject to the registration duty, and not the mixture itself.If you do import hand sanitiser products, then any REACH registration duties would fall to you as the EU-basedimporter in the supply chain. You would need to determine if each of the individual non-activesubstances/ingredients within the hand sanitiser trigger the registration threshold of 1 tonne per year or more.You will also need to decide if any of the substances are not subject to registration under REACH, for example, somesubstances such as water, are exempt. Further information about exemptions can be found in our short informationleaflet r information on registration there is a wide range on the ECHA website; a good place to start could be thewebpage ‘Your registration obligations’ registration-obligations).If you require any further help on REACH registration, email the REACH Helpdesk at ukreachca@hse.gov.uk.Article 95Article 95 of the Biocidal Products Regulation (BPR) requires that the active substance in a biocidal product has to besourced from one of the suppliers included on a specific list – known as the Article 95 ls/active-substance-suppliers).This does not mean you have to purchase directly from an Article 95 supplier, but you must be able to trace supplyback to one of these companies via proper records such as invoices. The list of Article 95 suppliers can be found onthe European Chemicals Agency (ECHA) website ctivesubstance-suppliers).During this exceptional time of increased demand due to the coronavirus pandemic, it may be necessary for handsanitiser manufacturers to find alternative suppliers of raw ingredients to supplement those obtained via regularsupply chains.HSE’s primary concern is that safe and effective biocidal hand sanitisers are available in the UK to help protectpeople during the coronavirus pandemic. HSE will adopt a pragmatic and proportionate approach to regulatoryrequirements that relate to supply chain obligations during this period. The focus of any HSE activity by inspectorswill be to ensure that products on the market are effective in combating the coronavirus and do not pose anunacceptable risk to people or the environment.

HSE would expect product manufacturers to have taken all reasonable steps to source ingredients in such a way thatthey are compliant with Article 95 obligations. However, HSE inspectors will take a sensible and proportionateapproach if they come across hand sanitisers that are not strictly in line with normal BPR supply chain requirementsunder Article 95, recognising the urgent wider need for safe and effective products.If you are going to use a source that is not Article 95 listed, keep a record of the actions you have taken to try tosource the active from Article 95 listed companies in case you are asked to justify that decision at some point in thefuture. For example, if there has been email communication with Article 95 listed suppliers and you have beenunsuccessful in obtaining a source of the active substance, then such emails could demonstrate reasonable steps totry to source ingredients that would be Article 95 compliant. Alternatively, if such enquiries are made over phone,ensure you keep a record of the call and follow up with email confirmation.In making commercial decisions, manufacturers need to be mindful of maintaining high levels of safety and efficacyof the products they make available to the public and others.TestingIt remains your responsibility to ensure the products you supply are suitably efficient, including meeting anynecessary testing standards. This also includes ensuring any claims for the products can be verified by supportingdata.British Standard BS EN 14885 outlines standard efficacy testing for disinfectant products; EN 14885 provides a list ofstandards for different types of products. Please note, EN 14885 does not provide detailed test methods but rather alist of other standards that should be used, eg EN 1500, EN 1276, EN 14476 etc.If your product requires BPR product authorisation (the information under the heading ‘Other requirements’ willhelp you determine this), the BPR efficacy guidance – -onbiocides-legislation, Volume II, Parts B C also provides in depth information on testing. Appendices 3 and 4 of theefficacy guidance contain a useful summary of the sort of testing normally expected for disinfectant products.Organisations like the NHS may also have specific requirements for hand sanitiser products which are intended to beused in the health care system. It is advisable to approach these organisations directly to check their requirements inadvance. The Department of Health and Social Care (DHSC) has also published details of specifications for handsanitisers and hand washes for use in the healthcare system ment-ppe.Other requirements

Other government departments such as the Department of Education (DfE) may have their own specificrequirements/recommendations. See the coronavirus (COVID-19) guidance on GOV.UK/coronavirus.The general product safety regulations inesses#generalproduct-safety-regulations) requires manufacturers to ensure that the products they make available to the publicand others are safe and effective. Therefore, they must ensure that the grade of chemicals they use does not impacton this. Manufacturers should therefore have an awareness of the specification and impurity profile of the chemicalsthey use, particularly regarding the presence of any hazardous substances such as methanol.You should also provide information on the products to the National Poisons Information pis.htm).Any workplace producing or using or storing hand sanitiser products must also comply with relevant health andsafety regulations.Additional requirements may apply to your hand sanitiser products depending on the active substance they contain.See the relevant section(s) in this document for more information.Ethanol-based productsEthanol (CAS 64-17-5; EC 200-578-6) has been supported for assessment under the BPR review programme for usein Product type 1 – human hygiene biocidal products (which would include hand sanitisers) and is still undergoingthat assessment. This means you do not need a product authorisation or any specific derogation from HSE to bringan ethanol-based hand sanitiser to the UK market – that would only be required once the review of ethanol hasbeen completed and it gains approval under BPR.Although there are no specific BPR requirements for the grade of ethanol that can be used in such biocidal products,World Health Organisation (WHO) guidance on making hand sanitisers recommends that pharmacopoeia gradechemicals are used. The European Pharmacopoeia specification for ethanol allows for maximum amounts ofcommon, potentially hazardous impurities. For example, methanol is identified as a potentially hazardous impuritythat should not exceed 200 ppm (0.02%). The WHO guidance however, is a guide, not a legal requirement.HM Revenue & Customs (HMRC) have provided industry with advice on changes to their rules for the supply ofethanol gel-for-coronavirus-covid-19) – HSE cannot provideadditional advice on HMRC’s position.You must also ensure that you comply with all of the requirements under the heading ‘General legal requirementsfor biocidal hand sanitiser products’.

Propan-2-ol-based productsPropan-2-ol (CAS 67-63-0; EC 200-661-7) has already been approved as an active substance under BPR for use inProduct type 1 – human hygiene biocidal products (which would include hand sanitisers). This means that handsanitiser products based on propan-2-ol would normally require UK BPR product authorisation before they can bemade available (supplied) and used in the UK. However, Article 55(1) of BPR) enables HSE to provide short-termderogations from the requirements for BPR authorisation in cases of danger to public health, animal health or theenvironment which cannot be contained by other means.WHO propan-2-ol formulationIn response to the current shortages in supply of hand sanitisers, HSE has issued a Critical Situation Permit underArticle 55(1) of BPR to enable hand sanitiser products, using the WHO-specified formulation based on propan-2-ol,to be quickly made available on the UK market. This derogation is only for the exact WHO-specified formulation, butit allows a broad number of companies or institutions to be permitted to supply and use the formulation, providedthey comply with specific conditions.While this action will enable manufacturers to supply hand sanitiser products in the UK quickly, HSE expectsmanufacturers to adhere to standards that protect people and the environment from hazardous chemicals.Companies and institutions wishing to make use of the existing derogation for the WHO formulation should emailbiocidesenquiries@hse.gov.uk with ’Propan-2-ol Article 55 notification form‘ in the subject line.There may be some delays due to the volume of notifications we expect to receive. You must wait for ourconfirmation before suppling or using the products in the UK.You must also ensure that you comply with all of the requirements under the heading ‘General legal requirementsfor biocidal hand sanitiser products’.Other propan-2-ol formulationsIf the hand sanitiser products you wish to make available (supply) use a propan-2-ol formulation that is different inany way from the WHO formulation, you will need to apply for a separate permit.As part of your application you will be required to submit a data package relating to the safety and efficacy of yourproduct.We will process any such requests urgently. However, a technical assessment of the data package is required toensure that the product meets the established standards that protect people and the

Coronavirus (COVID-19) manufacture and supply of hand sanitisers Manufacturers and suppliers of hand sanitisers must comply with the relevant laws. This may mean your product needs to be authorised by HSE. Check which regulations apply to your product . All hand cleaning and sanitising products (such as liquids, gels and soaps) are regulated in the UK. If you are manufacturing or importing .

Related Documents:

2 Current UK Coronavirus (COVID-19) situation and advice What is the current UK situation regarding Coronavirus? The current coronavirus alert level in the UK is 4, which means Covid-19 is in general circulation, transmission is high or rising and current social distancing measures and restrictions are in place. From 5 January 2021 the Government imposed a national lockdown. This means .

Questions fréquentes : COVID-19 et tuberculose Version 2, 22 avril 2020. Cette version remplace toutes les autres versions. Le nouveau coronavirus ou coronavirus 2 du syndrome respiratoire aigu sévère (SARS-CoV-2) est un nouveau coronavirus récemment découvert en 2019. Le virus est à l'origine de la maladie à coronavirus 2019 (COVID-19).

Coronavirus (COVID-19) Pandemic: Safe Opening and Operation Work Eligible for Public Assistance (Interim) FEMA Policy FP-104-21-0003 . BACKGROUND . Under the March 13, 2020, Coronavirus (COVID-19) nationwide emergency declaration. 1. and subsequent major disaster declarations for COVID-

2 Coronavirus: Coronavirus Disease (COVID-19) is an illness caused by a virus that can spread from person to person. The virus that causes COVID-19 is a new coronavirus that has spread throughout the world. Isolation: The practice of separating people infected with the virus (those who are sick with COVID-19 and those with no symptoms) from people whoare not infected.

We promise to keep you updated and share information as we have it. In the meantime, thank you for your patience as we all work through COVID-19 together. For the latest information on coronavirus (COVID-19) visit . coronavirus.ohio.gov. For questions about COVID-19’s effect on BWC not listed here,

May 17, 2021 · Coronavirus 2019 (COVID-19): Guidance for Travel Last updated May 18, 2021 Page 1 of 6. Coronavirus 2019 (COVID-19): Guidance for Travel . With the arrival of vaccines for COVID-19, DC residents can begin to resume leisure and other non-essential travel. This guidance provides updated reco

May 19, 2021 · Coronavirus 2019 (COVID-19): Guidance for Travel Last updated May 20, 2021 Page 1 of 6 Coronavirus 2019 (COVID-19): Guidance for Travel With the arrival of vaccines for COVID-19, DC residents can begin to resume leisure and other non-essential travel. This guidance provides updated recommendations for s

Coronavirus: Coronavirus Disease (COVID-19) is an illness caused by a virus that can spread from person -to-person. The virus that causes COVID -19 is a new coronavirus that has spread throughout the world. People with COVID-19 have had a wide range of symptoms reported - ranging from mild symptoms to severe illness. Symptoms